UGT Biocatalytic Glucuronide Production via Microbial Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing glucuronides, particularly using chemical approaches, face challenges such as poor yields and side reactions, and there is a lack of understanding and application of UDP-Glucuronyltransferases (UGTs) from microorganisms, limiting the microbial production of these valuable compounds.
Innovation Solution
Discovery and characterization of a versatile UDP-Glucuronyltransferase (UGT) from Streptomyces chromofuscus ATCC 49982, which is cloned and expressed in Escherichia coli, enabling the production of glucuronides with improved water solubility and antioxidant activity, and the use of genetically modified microorganisms to produce glucuronides in a biocatalytic process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If chemical approaches are used to produce glucuronides, then production can proceed without specialized enzymes, but yields are poor and side reactions occur
Solution Approach 1:
The patent replaces chemical synthesis methods with a biocatalytic system using genetically modified microorganisms expressing UDP-glucuronyltransferase. This substitution of chemical mechanisms with biological systems enables high-yield glucuronide production while eliminating the side reactions inherent in chemical approaches.
Solution Approach 2:
The genetically modified microorganism serves as a self-contained biocatalytic factory, possessing endogenous UDP-glucuronic acid synthesis pathways and expressing the UGT enzyme to autonomously produce glucuronides from simple substrates without requiring external enzyme addition or complex chemical reagents.
2Adaptability or versatility
If microbial production of glucuronides is attempted without understanding UGTs from microorganisms, then research can proceed with available tools, but the potential for microbial production is limited
Solution Approach 1:
The patent demonstrates that a single UGT enzyme from Streptomyces chromofuscus can catalyze glucuronidation of diverse substrates including polyphenols, flavonoids, and other phenolic compounds. This universal catalytic capability significantly expands the scope of compounds that can be produced via microbial fermentation.
Solution Approach 2:
The patent optimizes multiple parameters including genetic modification strategies (overexpression constructs, promoter selection), cultivation conditions (pH, temperature, induction timing), and substrate concentrations to maximize UGT expression and glucuronide production efficiency in the microbial system.
3Reliability
If polyphenols are used directly, then natural bioactivity is maintained, but water solubility and bioavailability are poor
Solution Approach 1:
The UGT enzyme acts as an intermediary that mediates the transformation of hydrophobic polyphenols into hydrophilic glucuronide conjugates. This enzymatic modification introduces polar glucuronic acid moieties that enhance water solubility and bioavailability while preserving the core bioactive structure of the original polyphenol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves efficient production of glucuronides with enhanced water solubility and bioavailability, providing a sustainable and selective method for synthesizing these compounds, and demonstrates the potential for microbial production of valuable glucuronidated metabolites.
Implementation Method 1
Glycosyltransferases can be used as an effective tool to create glycosides from natural products. UGTs transfer the glucuronic acid moiety from uridine 5'-diphosphoglucuronic acid (UDP-glucuronic acid) to various exogenous and endogenous compounds.
Implementation Method 2
the use of genetically modified microorganisms to produce glucuronides in a biocatalytic process
Data Source
AI summary
The present invention relates to an in vitro or in vivo process for producing a glucuronide comprising a glucuronic acid moiety bound to a phenolic hydroxyl group or a phenolic carboxyl group. Also provided are expression vectors, nucleic acids, polypeptides, and recombinant microbial cells useful in carrying out the process and prodrugs produced by the process.